The Company announced a decent subscription number where the tranche was 6.1x subscribed.
Having said that, I don't see any interesting "anchors" like the ones in iX Biopharma. The share price has a decent debut today but as usual, don't be the last to hold the baby.
Let's see how this stock debuts and good luck to those who got it. :)